The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis

Harold I. Salmons, Christopher Gow, Afton K. Limberg, Jacob W. Bettencourt, Mason F. Carstens, Ashley N. Payne, Mark E. Morrey, Joaquin Sanchez-Sotelo, Daniel J. Berry, Amel Dudakovic, Matthew P. Abdel

Research output: Contribution to journalArticlepeer-review


AdipoRon is an adiponectin receptor 1, 2 (ADIPOR1 and ADIPOR2) agonist with numerous reported physiological benefits in murine models of human disease, including a proposed reduction in fibrosis. However, AdipoRon has never been investigated in rabbits, which provide a robust model for orthopedic conditions. We examined the safety of intravenous (IV) AdipoRon in New Zealand White (NZW) female rabbits surgically stressed by a procedure that mimics human arthrofibrosis. Fifteen female NZW rabbits were prospectively studied using increasing AdipoRon doses based on established literature. AdipoRon was dissolved in dimethyl sulfoxide (DMSO), diluted in normal saline, and administered IV preoperatively and for 5 subsequent days postoperatively. The primary outcome was overall toxicity to rabbits, whereas secondary outcomes were change in rabbit weights and hemodynamics and defining acid-base characteristics of the drug formulation. Two rabbits expired during preoperative drug administration at 25 mg/kg. Remaining rabbits received preoperative doses of DMSO (vehicle), 2.5, 5, or 10 mg/kg of AdipoRon without complications. On postoperative day 1, one rabbit sustained a tonic-clonic seizure after their second dose of 10 mg/kg AdipoRon. The remaining 12 rabbits (4 in each group) received six serial doses of vehicle, 2.5, or 5 mg/kg of AdipoRon without adverse effects. All formulations of AdipoRon were within safe physiological pH ranges (4-5). We are the first to report the use of IV AdipoRon in a surgically stressed rabbit model of orthopedic disease. AdipoRon doses of 5 mg/kg or less appear to be well-tolerated in female NZW rabbits. We provided the first in vivo toxicity assessment and dose optimization of a new antifibrotic experimental medication, AdipoRon, in a surgically stressed rabbit model of knee arthrofibrosis.

Original languageEnglish (US)
Pages (from-to)154-159
Number of pages6
JournalTissue Engineering - Part C: Methods
Issue number4
StatePublished - Apr 1 2023


  • adiponectin
  • arthrofibrosis
  • intravenous
  • knee
  • toxicity

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering


Dive into the research topics of 'The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis'. Together they form a unique fingerprint.

Cite this